查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1452456

磁性奈米粒子市场预测：~2030年

Magnetic Nanoparticles Market Research Report Forecast to 2030
出版日期: | 出版商: Market Research Future | 英文 104 Pages | 订单完成后即时交付

价格

磁性奈米颗粒由于其特殊的性质，在不同领域有广泛的应用。尤其广泛应用于磁转染、光热疗法、光动力疗法、标靶药物传递、磁热疗法等癌症治疗。

据信，废水处理产业对磁性奈米颗粒的需求不断增加，这将为美国和中国的磁性奈米颗粒市场提供成长机会。

美国和中国的磁性奈米粒子市场预计将受到生物医学和医疗保健领域扩张的推动。在预处理试剂盒过程中越来越多地使用磁性奈米颗粒技术正在推动美国磁性奈米颗粒市场的发展。

该报告调查了全球磁性奈米粒子市场，并提供了市场定义和概述、影响市场成长和市场机会的因素分析、市场规模趋势和预测、各个细分市场和地区的细分以及竞争环境。其中彙编了主要公司的概况。

目录

第 1 章市场概况

第二章 市场动态

  • 概述
  • 促进因素
    • 美国生物医学和医疗保健产业的扩张
    • 中国生物医学和医疗保健产业的扩张
    • 在预处理试剂盒中增加磁性奈米粒子技术的使用
  • 抑制因素
    • 中国磁性奈米粒子材料价格波动
    • 美国磁性奈米颗粒材料价格波动
    • 磁性奈米颗粒材料的毒性和生物相容性
  • 机会
    • 增加磁性奈米粒子在水处理的使用
  • 趋势
    • 利用磁性分离和浓缩目标病原体的磁性奈米粒子核心技术
    • 使用磁性奈米颗粒 (MNPS) 的败血症奈米诊断技术

第三章 磁性奈米粒子官能基与尺寸的定性分析

  • 按功能组
  • 按尺寸
  • 生物诊断中使用的基于磁珠的方法：概述

第四章 竞争状况

  • 竞争对手分析
  • 市场占有率分析
  • 主要成长策略（生物诊断最终用户）
  • 竞争标桿
  • 开发数量领先
  • 主要发展/成长策略
  • 主要公司财务数据

第五章 公司简介

  • QIAGEN NV
  • BIONEER CORPORATION
  • T2 BIOSYSTEMS, INC.
  • THERMO FISHER SCIENTIFIC INC.
  • HOFFMANN-LA ROCHE LTD
  • CREATIVE BIOGENE
  • MAGGENOME TECHNOLOGIES PVT. LTD.
  • DAAN GENE CO., LTD.
  • MAGBIO GENOMICS INC.
  • BECKMAN COULTER INC.（DANAHER CORPORATION）
  • XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD
  • GUANGZHOU DONGSHENG BIOTECH CO., LTD
  • GENEAID BIOTECH LTD.
  • TIANGEN BIOTECH(BEIJING)CO., LTD.
  • WUXI NEST BIOTECHNOLOGY CO., LTD

Market Overview

Magnetic nanoparticles define as the use of tiny particles that possess magnetic properties are typically ranging from 1 to 500 nanometres in size. Magnetic Nanoparticles is receptor immobilized magnetic nanoparticles bind specifically to bacteria and viruses. It is a core technology that can separate and concentrate target pathogens through magnetism. After directly synthesizing magnetic nanoparticles, self-coating is performed to prevent aggregation and then, various functional groups possessed are fixed to realize a concentrating effect. These nanoparticles are often composed of magnetic materials such as iron, cobalt, or nickel, or their alloys. They exhibit unique characteristics such as magnetic behavior at the nanoscale, which can be manipulated and controlled for various applications including wastewater treatment, electronics, healthcare sector, biomedical, energy and other application. Magnetic nanoparticles have a wide range of uses in different fields due to their special properties. Most notably, magnetic nanoparticles are frequently employed in cancer treatment methods like magnetofection, photothermal therapy, photodynamic therapy, targeted drug delivery, and magnetic hyperthermia.

However, the fluctuations in the prices of magnetic nanoparticles materials and toxicity and biocompatibility of magnetic nanoparticles materials will likely restrain market growth. On the other hand, to rise in demand for magnetic nanoparticles from wastewater industry will create growth opportunities for the US and China Magnetic Nanoparticles market.

Market Segmentation

The functional group of magnetic particles has been majorly classified into -COOH, -NH2, -SiO2, -Tosyl , and -Streptavidin.

The size range of magnetic particles has been majorly classified into 100, 200, 300, and 500 nm. The size of magnetic particles can greatly impact their magnetic behavior, surface area, stability, and interactions with other molecules or systems.

Regional Analysis

The US and China Magnetic Nanoparticles market is expected to be driven by increasing expansion of biomedical and healthcare sector in US and China. The Increase usage of magnetic nanoparticles technology in process of pretreatment kits are driving the US Magnetic Nanoparticles market.

Major Players

Qiagen N. V., Bioneer Corporation, T2 Biosystems Inc., Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Creative Biogene, Baker Coulters Inc. (Danaher Corporation), MagBio Genomics Inc., DaAn Gene Co., Ltd, and MagGenome Technologies Pvt. Ltd among others are the major companies in the Magnetic Nanoparticles Market.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 DEFINITION
  • 1.2 SCOPE OF THE STUDY
  • 1.3 RESEARCH OBJECTIVE
  • 1.4 MARKET STRUCTURE
  • 1.5 LIST OF ASSUMPTIONS

2 MARKET DYNAMICS

  • 2.1 OVERVIEW
  • 2.2 DRIVERS
    • 2.2.1 EXPANSION OF BIOMEDICAL AND HEALTHCARE SECTOR IN US
    • 2.2.2 EXPANSION OF BIOMEDICAL AND HEALTHCARE SECTOR IN CHINA
    • 2.2.3 INCREASE USAGE OF MAGNETIC NANOPARTICLES TECHNOLOGY IN PRETREATMENT KITS
  • 2.3 RESTRAINTS
    • 2.3.1 FLUCTUATIONS IN THE PRICES OF MAGNETIC NANOPARTICLES MATERIALS IN CHINA
    • 2.3.2 FLUCTUATIONS IN THE PRICES OF MAGNETIC NANOPARTICLES MATERIALS IN US
    • 2.3.3 TOXICITY AND BIOCOMPATIBILITY OF MAGNETIC NANOPARTICLES MATERIALS
  • 2.4 OPPORTUNITIES
    • 2.4.1 INCREASING USE OF MAGNETIC NANOPARTICLES FOR WATER TREATMENT
  • 2.5 TRENDS
    • 2.5.1 CORE TECHNOLOGY OF MAGNETIC NANOPARTICLES THAT CAN SEPARATE AND CONCENTRATE TARGET PATHOGENS THROUGH MAGNETISM
    • 2.5.2 NANODIAGNOSTIC TECHNOLOGIES FOR SEPSIS USING MAGNETIC NANOPARTICLES (MNPS)

3 QUALITATIVE ANALYSIS ON FUNCTIONAL GROUP AND SIZE FOR MAGNETIC NANOPARTICLES

  • 3.1 BY FUNCTIONAL GROUP
  • 3.2 BY SIZE
  • 3.3 OVERVIEW OF MAGNETIC BEAD-BASED METHOD EMPLOYED IN BIO-DIAGNOSTICS

4 COMPETITIVE LANDSCAPE

  • 4.1 INTRODUCTION
  • 4.2 COMPETITIVE ANALYSIS
  • 4.3 MARKET SHARE ANALYSIS
  • 4.4 MAJOR GROWTH STRATEGY IN THE MAGNETIC NANOPARTICES MARKET (BIO-DIAGNOSTIC END USERS)
  • 4.5 COMPETITIVE BENCHMARKING
  • 4.6 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN MAGNETIC NANOPARTICLES MARKET
  • 4.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 4.7.1 PRODUCT LAUNCH/ PRODUCT DEVELOPMENT
    • 4.7.2 PARTNERSHIP/COLLABORATION
  • 4.8 MAJOR PLAYER FINANCIAL*
    • 4.8.1 SALES, OPERATING INCOME, R&D EXPENDITURE 2022*

5 COMPANY PROFILES

  • 5.1 QIAGEN NV
    • 5.1.1 COMPANY OVERVIEW
    • 5.1.2 FINANCIAL OVERVIEW
    • 5.1.3 PRODUCTS OFFERED
    • 5.1.4 KEY DEVELOPMENTS
    • 5.1.5 SWOT ANALYSIS
    • 5.1.6 KEY STRATEGIES
  • 5.2 BIONEER CORPORATION
    • 5.2.1 COMPANY OVERVIEW
    • 5.2.2 FINANCIAL OVERVIEW
    • 5.2.3 PRODUCTS OFFERED
    • 5.2.4 KEY DEVELOPMENTS
    • 5.2.5 SWOT ANALYSIS
    • 5.2.6 KEY STRATEGIES
  • 5.3 T2 BIOSYSTEMS, INC.
    • 5.3.1 COMPANY OVERVIEW
    • 5.3.2 FINANCIAL OVERVIEW
    • 5.3.3 PRODUCTS OFFERED
    • 5.3.4 KEY DEVELOPMENTS
    • 5.3.5 SWOT ANALYSIS
    • 5.3.6 KEY STRATEGIES
  • 5.4 THERMO FISHER SCIENTIFIC INC.
    • 5.4.1 COMPANY OVERVIEW
    • 5.4.2 FINANCIAL OVERVIEW
    • 5.4.3 PRODUCTS OFFERED
    • 5.4.4 KEY DEVELOPMENTS
    • 5.4.5 SWOT ANALYSIS
    • 5.4.6 KEY STRATEGIES
  • 5.5 HOFFMANN-LA ROCHE LTD
    • 5.5.1 FINANCIAL OVERVIEW
    • 5.5.2 PRODUCTS OFFERED
    • 5.5.3 KEY DEVELOPMENTS
    • 5.5.4 SWOT ANALYSIS
    • 5.5.5 KEY STRATEGIES
  • 5.6 CREATIVE BIOGENE
    • 5.6.1 COMPANY OVERVIEW
    • 5.6.2 FINANCIAL OVERVIEW
    • 5.6.3 PRODUCTS OFFERED
    • 5.6.4 KEY DEVELOPMENTS
    • 5.6.5 SWOT ANALYSIS
    • 5.6.6 KEY STRATEGIES
  • 5.7 MAGGENOME TECHNOLOGIES PVT. LTD.
    • 5.7.1 COMPANY OVERVIEW
    • 5.7.2 FINANCIAL OVERVIEW
    • 5.7.3 PRODUCTS OFFERED
    • 5.7.4 KEY DEVELOPMENTS
    • 5.7.5 SWOT ANALYSIS
    • 5.7.6 KEY STRATEGIES
  • 5.8 DAAN GENE CO., LTD.
    • 5.8.1 COMPANY OVERVIEW
    • 5.8.2 FINANCIAL OVERVIEW
    • 5.8.3 PRODUCTS OFFERED
    • 5.8.4 KEY DEVELOPMENTS
    • 5.8.5 SWOT ANALYSIS
    • 5.8.6 KEY STRATEGIES
  • 5.9 MAGBIO GENOMICS INC.
    • 5.9.1 COMPANY OVERVIEW
    • 5.9.2 FINANCIAL OVERVIEW
    • 5.9.3 PRODUCTS OFFERED
    • 5.9.4 KEY DEVELOPMENTS
    • 5.9.5 SWOT ANALYSIS
    • 5.9.6 KEY STRATEGIES
  • 5.10 BECKMAN COULTER INC. (DANAHER CORPORATION)
  • 5.10. COMPANY OVERVIEW
  • 5.10. FINANCIAL OVERVIEW
  • 5.10. PRODUCTS OFFERED

5.10.4KEY DEVELOPMENTS

5.10.5SWOT ANALYSIS

5.10.6KEY STRATEGIES

  • 5.11 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD

5.11.1COMPANY OVERVIEW

5.11.2FINANCIAL OVERVIEW

5.11.3PRODUCTS OFFERED

5.11.4KEY DEVELOPMENTS

5.11.5SWOT ANALYSIS

5.11.6KEY STRATEGIES

  • 5.12 GUANGZHOU DONGSHENG BIOTECH CO., LTD

5.12.1COMPANY OVERVIEW

5.12.2FINANCIAL OVERVIEW

5.12.3PRODUCTS OFFERED

5.12.4KEY DEVELOPMENTS

5.12.5SWOT ANALYSIS

5.12.6KEY STRATEGIES

  • 5.13 GENEAID BIOTECH LTD.

5.13.1COMPANY OVERVIEW

5.13.2FINANCIAL OVERVIEW

5.13.3PRODUCTS OFFERED

5.13.4KEY DEVELOPMENTS

5.13.5SWOT ANALYSIS

5.13.6KEY STRATEGIES

  • 5.14 TIANGEN BIOTECH(BEIJING)CO., LTD.98

5.14.1COMPANY OVERVIEW

5.14.2FINANCIAL OVERVIEW

5.14.3PRODUCTS OFFERED

5.14.4KEY DEVELOPMENTS

5.14.5SWOT ANALYSIS

5.14.6KEY STRATEGIES

  • 5.15 WUXI NEST BIOTECHNOLOGY CO., LTD

5.15.1COMPANY OVERVIEW

5.15.2FINANCIAL OVERVIEW

5.15.3PRODUCTS OFFERED

5.15.4KEY DEVELOPMENTS

5.15.5SWOT ANALYSIS

5.15.6KEY STRATEGIES

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS 15
  • TABLE 2 PRODUCT LAUNCH/PRODUCT DEVELOPMENT 47
  • TABLE 3 PARTNERSHIP/COLLABORATION 48
  • TABLE 4 SALES, OPERATING INCOME, R & D EXPENDITURE 2022 49
  • TABLE 5 QIAGEN N.V.: PRODUCTS OFFERED 52
  • TABLE 6 QIAGEN N. V.: KEY DEVELOPMENTS 53
  • TABLE 7 BIONEER CORPORATION: PRODUCTS OFFERED 56
  • TABLE 8 BIONEER CORPORATION: KEY DEVELOPMENTS 57
  • TABLE 9 T2 BIOSYSTEMS, INC.: PRODUCTS OFFERED 60
  • TABLE 10 T2 BIOSYSTEMS, INC.: KEY DEVELOPMENTS 60
  • TABLE 11 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 64
  • TABLE 12 HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 68
  • TABLE 13 CREATIVE BIOGENE: PRODUCTS OFFERED 71
  • TABLE 14 MAGGENOME TECHNOLOGIES PVT. LTD.: PRODUCTS OFFERED 74
  • TABLE 15 MAGGENOME TECHNOLOGIES PVT. LTD.: KEY DEVELOPMENTS 75
  • TABLE 16 DAAN GENE CO., LTD: PRODUCTS OFFERED 78
  • TABLE 17 MAGBIO GENOMICS INC.: PRODUCTS OFFERED 81
  • TABLE 18 BECKMAN COULTER INC. (DANAHER CORPORATION): PRODUCTS OFFERED 85
  • TABLE 19 BECKMAN COULTER INC. (DANAHER CORPORATION): KEY DEVELOPMENTS 85
  • TABLE 20 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD: PRODUCTS OFFERED 88
  • TABLE 21 GUANGZHOU DONGSHENG BIOTECH CO., LTD: PRODUCTS OFFERED 92
  • TABLE 22 GENEAID BOITECH LTD.: PRODUCTS OFFERED 95
  • TABLE 23 GENEAID BOITECH LTD.: KEY DEVELOPMENTS 95
  • TABLE 24 TIANGEN BIOTECH (BEIJING) CO., LTD.: PRODUCTS OFFERED 99
  • TABLE 25 WUXI NEST BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 102

LIST OF FIGURES

  • FIGURE 1 MAGNETIC NANOPARTICLES MARKET: MARKET STRUCTURE 14
  • FIGURE 2 MARKET DYNAMICS: US AND CHINA MAGNETIC NANOPARTICLES MARKET 16
  • FIGURE 3 MARKET SIZE OF BIOMEDICAL INDUSTRY IN CHINA FROM 2015 TO 2019 (BILLION YUAN) 18
  • FIGURE 4 USE OF MNPS FOR BIOMEDICAL APPLICATIONS 19
  • FIGURE 5 SCHEMATIC PROCEDURE FOR NUCLEIC ACID PURIFICATION BY MEANS OF MAGNETIC NANOPARTICLE (MNPS) 21
  • FIGURE 6 DRIVERS: IMPACT ANALYSIS 22
  • FIGURE 7 PRICES FOR IRON ORE MARKET IN CHINA, 2019-2022, USD PER TONS 23
  • FIGURE 8 PRICES FOR IRON ORE MARKET IN US, 2019-2022, USD PER TONS 25
  • FIGURE 9 RESTRAINT: IMPACT ANALYSIS 27
  • FIGURE 10 RESTRAINT: IMPACT ANALYSIS 28
  • FIGURE 11 NANODIAGNOSTIC TECHNOLOGIES FOR SEPSIS USING MAGNETIC NANOPARTICLES (MNPS) 31
  • FIGURE 12 FIGURE A) REPRESENTS SCHEMATIC REPRESENTATION OF T2MR DIAGNOSTIC PLATFORM 32
  • FIGURE 13 FIGURE B) REPRESENTS NANOMAGNETO-DNA ASSAY FOR THE DETECTION OF BACTERIAL 16S RRNA 33
  • FIGURE 14 FIGURE C) REPRESENTS SERS SUBSTRATES TO ANCHOR ANTIBODY-DECORATED 34
  • FIGURE 15 MARKET SHARE ANALYSIS, 2022 43
  • FIGURE 16 COMPETITIVE BENCHMARKING 44
  • FIGURE 17 COMPETITIVE BENCHMARKING 45
  • FIGURE 18 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN MAGNETIC NANOPARTICLES MARKET (BIO-DIAGNOSTIC COMPANIES) 46
  • FIGURE 19 QIAGEN N. V.: FINANCIAL OVERVIEW SNAPSHOT 51
  • FIGURE 22 T2 BIOSYSTEMS, INC.: FINANCIAL OVERVIEW SNAPSHOT 59
  • FIGURE 24 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 63
  • FIGURE 26 HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 67
  • FIGURE 29 MAGGENOME TECHNOLOGIES PVT. LTD.: SWOT ANALYSIS 75
  • FIGURE 30 DAAN GENE CO., LTD: SWOT ANALYSIS 79
  • FIGURE 32 BECKMAN COULTER INC. (DANAHER CORPORATION): FINANCIAL OVERVIEW SNAPSHOT 84
  • FIGURE 33 BECKMAN COULTER INC. (DANAHER CORPORATION): SWOT ANALYSIS 86